☆ 4.6 Article

Identification and validation of a plasma metabolomics-based model for risk stratification of intrahepatic cholangiocarcinoma

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

Dimitrios Moris et al.

Summary: Intrahepatic cholangiocarcinoma (ICC) is a common primary liver tumor, and the choice of treatment depends on the patient's condition. Doublet chemotherapy with gemcitabine and cisplatin has been the most effective first-line regimen, but triplet regimens and immunotherapy may also be effective. Combining systemic therapy with locoregional therapies and molecular targeted therapy have been developed to improve the treatment outcomes. Recent data showed that combining durvalumab with standard cytotoxic therapy improved survival in ICC patients.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Quercetin Regulates Key Components of the Cellular Microenvironment during Early Hepatocarcinogenesis

Itayetzi Reyes-Avendano et al.

Summary: Quercetin has been found to reduce tumor microenvironment components and the expression of ABCC3, a marker of HCC progression and multi-drug resistance, in the early stages of hepatocellular carcinoma.

ANTIOXIDANTS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma

Jinkai Liu et al.

Summary: The study conducted integrative metabolomics analysis on the altered metabolites in HCC patients, revealing distinct clusters of metabolites in serum, liver tissue, and stool samples that differed significantly from healthy controls. Elevated and depleted metabolites identified in portal vein samples may play a role in HCC development. Linoleic acid and phenol were found to inhibit HCC proliferation, suggesting their potential as protective metabolites.

GUT (2022)

Add to Collection

Review Gastroenterology & Hepatology

Metabolic reprogramming in cholangiocarcinoma

Chiara Raggi et al.

Summary: Metabolic reprogramming is a characteristic of cancer, allowing tumor cells to survive and proliferate in resource-limited conditions. Cholangiocarcinoma, the second most common form of primary liver cancer, is associated with metabolic alterations such as increased aerobic glycolysis and glutamine anaplerosis. Therapeutic interventions targeting these metabolic changes may have potential benefits for treating cholangiocarcinoma.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Review Oncology

Anti-Cancer Effect of Gingerol in Cancer Prevention and Treatment

Sana Nafees et al.

Summary: Gingerol, an active component of ginger, shows potential in cancer treatment by modulating various cell signaling pathways associated with cancer. Both in vitro and in vivo studies, as well as clinical trials, support the efficacy of gingerol in cancer. Natural agents like gingerol are being explored in clinical trials against different types of cancer, highlighting recent advancements in cancer therapies.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Oncology

Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease

Ovie Utuama et al.

Summary: The study indicates that in patients with resectable intrahepatic cholangiocarcinoma, neoadjuvant chemotherapy (NAC) is associated with improved overall survival compared to upfront surgery in those at high risk of treatment failure. However, for patients with stage II-III disease, NAC appears to show a potential benefit.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Cell Biology

Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects

Parina Asgharian et al.

Summary: Pancreatic cancer is a deadly malignancy with increasing mortality rates worldwide. The use of flavonoids like quercetin has shown promising anticancer abilities in controlling and treating pancreatic cancer.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Add to Collection

Article Oncology

Metabolomics in cancer research and emerging applications in clinical oncology

Daniel R. Schmidt et al.

Summary: Cancer has complex effects on cellular and systemic metabolism, with metabolomics playing a crucial role in providing insights for cancer diagnosis, monitoring, and therapy. Advances in technology have expanded the applications of metabolomics in clinical research, with the potential to further enhance cancer patient management in the future.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features

Hyo Jung Park et al.

Summary: Current prognostic systems for intrahepatic cholangiocarcinoma rely on surgical pathology data and are not applicable to a preoperative setting. The study aimed to develop and validate preoperative models to predict postsurgical outcomes in mass-forming IHCC patients. The results suggest that a model integrating clinical, CT, and radiomics information may be useful for the preoperative assessment of postsurgical outcomes in patients with mass-forming IHCC.

EUROPEAN RADIOLOGY (2021)

Add to Collection

Review Medicine, Research & Experimental

Emerging impact of quercetin in the treatment of prostate cancer

Soudeh Ghafouri-Fard et al.

Summary: Quercetin is a flavonoid agent found in fruits and vegetables, known for its anti-inflammatory, antioxidant, and anticancer effects, specifically targeting prostate cancer. It can inhibit cell cycle transition and induce apoptosis in neoplastic cells, showing differential cytotoxic effects on cancerous cells compared to normal prostate cells. Moreover, quercetin may enhance the effects of other therapeutic options against prostate cancer, such as in combination with TRAIL as a novel modality for treatment.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Engineering, Environmental

Metabolomics and lipidomics study unveils the impact of polybrominated diphenyl ether-47 on breast cancer mice

Juntong Wei et al.

JOURNAL OF HAZARDOUS MATERIALS (2020)

Add to Collection

Review Oncology

Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives

Nikolaos Machairas et al.

EJSO (2020)

Add to Collection

Review Gastroenterology & Hepatology

Liver resection and transplantation for intrahepatic cholangiocarcinoma

Vincenzo Mazzaferro et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Oncology

The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma

Amika Moro et al.

ANNALS OF SURGICAL ONCOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?

Ariella M. Altman et al.

HEPATOBILIARY SURGERY AND NUTRITION (2020)

Add to Collection

Article Oncology

Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers

Zi-Jia Zhu et al.

JOURNAL OF CANCER (2020)

Add to Collection

Article Gastroenterology & Hepatology

Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma

Paola Bertuccio et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Review Gastroenterology & Hepatology

Anatomical, histomorphological and molecular classification of cholangiocarcinoma

Timothy Kendall et al.

LIVER INTERNATIONAL (2019)

Add to Collection

Review Cell Biology

Identification of bioactive metabolites using activity metabolomics

Markus M. Rinschen et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer

Lianyuan Tao et al.

METABOLOMICS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism

Marjorie Reyes-Farias et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Biochemical Research Methods

Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients

Julia Debik et al.

JOURNAL OF PROTEOME RESEARCH (2019)

Add to Collection

Article Oncology

Intrahepatic Cholangiocarcinoma

Ramy El-Diwany et al.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2019)

Add to Collection

Article Gastroenterology & Hepatology

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis

Jesus M. Banales et al.

HEPATOLOGY (2019)

Add to Collection

Review Oncology

Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients

Atsushi Hiraoka et al.

LIVER CANCER (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Applications of metabolomics to study cancer metabolism

Akash K. Kaushik et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Add to Collection

Review Cell Biology

Quercetin: A functional dietary flavonoid with potential chemo-preventive properties in colorectal cancer

Saber G. Darband et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas

S. R. Rosario et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Surgery

Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma

B. Le Roy et al.

BRITISH JOURNAL OF SURGERY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease

Jelske N. van der Veen et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)

Add to Collection

Article Medicine, General & Internal

Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study

Tilman Kuehn et al.

BMC MEDICINE (2016)

Add to Collection

Article Oncology

Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis

John R. Bergquist et al.

JOURNAL OF SURGICAL ONCOLOGY (2016)

Add to Collection

Article Endocrinology & Metabolism

Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics

Emily G. Armitage et al.

METABOLOMICS (2016)

Add to Collection

Article Oncology

Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma

Malini D. Sur et al.

ANNALS OF SURGICAL ONCOLOGY (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Inositol Phosphate Recycling Regulates Glycolytic and Lipid Metabolism That Drives Cancer Aggressiveness

Daniel I. Benjamin et al.

ACS CHEMICAL BIOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

John Bridgewater et al.

JOURNAL OF HEPATOLOGY (2014)

Add to Collection

Article Oncology

Quercetin in Cancer Prevention and Therapy

Salvatore Chirumbolo

INTEGRATIVE CANCER THERAPIES (2013)

Add to Collection

Article Oncology

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

Yizhou Wang et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Add to Collection

Article Oncology

Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

Mechteld C. de Jong et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Review Oncology

Prognostic versus predictive value of biomarkers in oncology

C. N. A. M. Oldenhuis et al.

EUROPEAN JOURNAL OF CANCER (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.